Table 1.
Compound | Growth Inhibition (%) | Aflatoxin Inhibition (%) | ||
---|---|---|---|---|
50 μm | 100 μm | 50 μm | 100 μm | |
L1 | 0.6 ± 0.3 | 0.5 ± 0.6 | 6.1 ± 0.8 | 1.1 ± 0.3 |
L2 | 47.5 ± 2.5* | 51.7 ± 2.3* | 26.7 ± 2.4* | 17.7 ± 9.5* |
L3 | 25.9 ± 1.6* | 25.6 ± 2.3* | 24.8 ± 3.0* | 25.7 ± 4.7* |
L4 | 0.4 ± 0.4 | 0.7 ± 0.6 | 13.8 ± 1.8* | 20.7 ± 1.4* |
L5 | 23.8 ± 1.5* | 43.9 ± 1.9* | 78.0 ± 6.9 * | 92.3 ± 4.2* |
L6 | 5.8 ± 0.8* | 21.8 ± 1.7* | 41.8 ± 2.7* | 48.6 ± 1.4* |
1 | — | — | 0.6 ± 0.7 | 6.6 ± 0.4 |
2 | 59.7 ± 1.4* | 73.6 ± 3.0* | 52.0 ± 3.3* | 72.7 ± 3.9* |
3 | 40.5 ± 1.3* | 51.0 ± 1.9* | 61.1 ± 2.4* | 79.0 ± 2.2* |
4 | 28.0 ± 0.6* | 62.7 ± 2.4* | 48.8 ± 2.2* | 62.1 ± 1.4* |
5 | 0.6 ± 0.3 | 1.1 ± 0.4 | 36.6 ± 2.0* | 67.3 ± 2.1* |
6 | 1.0 ± 0.3 | 6.2 ± 0.9* | 60.7 ± 1.2* | 67.8 ± 3.4* |
Statistical differences between treated and non-treated samples were reported. (*) p-value < 0.001.